[HTML][HTML] Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous …

…, L Cerroni, B Dreno, EC Vonderheid - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
Mycosis fungoides (MF) and Sézary syndrome (SS), the major forms of cutaneous T-cell
lymphoma, have unique characteristics that distinguish them from other types of non-Hodgkin's …

Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas

EC Vonderheid, MG Bernengo, G Burg, M Duvic… - Journal of the American …, 2002 - Elsevier
… Author links open overlay panel Prepared on behalf of the ISCL by , Eric C. Vonderheid MD
… the Cologne conference proceedings were presented (Eric Vonderheid, MD). In addition, …

Genomic landscape of cutaneous T cell lymphoma

…, L Barbarotta, FM Foss, A Subtil, EC Vonderheid… - Nature …, 2015 - nature.com
Cutaneous T cell lymphoma (CTCL) is a non-Hodgkin lymphoma of skin-homing T lymphocytes.
We performed exome and whole-genome DNA sequencing and RNA sequencing on …

Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses

…, RB Shane, SR Lessin, EC Vonderheid - Blood, The Journal …, 1999 - ashpublications.org
Progression of cutaneous T-cell lymphoma (CTCL) is associated with profound defects in
cell-mediated immunity and depressed production of cytokines, which support cell-mediated …

Infections complicating mycosis fungoides and Sezary syndrome

PI Axelrod, B Lorber, EC Vonderheid - Jama, 1992 - jamanetwork.com
Objective. —To determine, in patients with mycosis fungoides and Sézary syndrome, the
incidence of infections, the importance of nosocomial infections, and the epidemiologic factors …

Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells

BR Vowels, M Cassin, EC Vonderheid… - Journal of Investigative …, 1992 - Elsevier
Sezary syndrome (SzS), the leukemic stage of cutaneous T-cell lymphoma (CTCL), is
typically a CD4 + T-cell lympho-proliferative disease characterized by numerous immunologic …

Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders

EC Vonderheid, A Sajjadian, ME Kadin - Journal of the American Academy …, 1996 - Elsevier
Background: The spectrum of primary cutaneous CD30 + lymphoproliferative disease consists
of lymphomatoid papulosis (LyP) at one extreme and CD30+ peripheral T-cell lymphoma (…

Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma

EC Vonderheid, ET Tan, AF Kantor, L Shrager… - Journal of the American …, 1989 - Elsevier
Complete responses lasting from 4 to 14 years were documented in 65 of 331 (20%) patients
with cutaneous T cell lymphoma treated with topical mechlorethamine (HN2) between …

Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous …

Q Zhang, I Nowak, EC Vonderheid… - Proceedings of the …, 1996 - National Acad Sciences
Signaling through the interleukin 2 receptor (IL-2R) involves phosphorylation of several
proteins including Jak3, STAT5, and, in preactivated cells, STAT3. In the present study, we …

Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma

…, EC Vonderheid, C Nichols, D Virok, C Chang… - The Journal of …, 2003 - rupress.org
We have used cDNA arrays to investigate gene expression patterns in peripheral blood
mononuclear cells from patients with leukemic forms of cutaneous T cell lymphoma, primarily …